\-\ Texto\\:\\ \ \(0\)\
\-\ palpable\\ mass\\ in\\ the\\ medial\\ elbow\\.\ \(0\)\
\-\ treatment\\ is\\ usually\\ surgical\\ excision\\.\ \(0\)\
\-\ radiographic\\ examination\\ demonstrates\\ a\\ rounded\\ soft\\ tissue\\ mass\\ in\\ the\\ medial\\ aspect\\ of\\ the\\ elbow\\.\ \(0\)\
\-\ mri\\ findings\\ include\\ a\\ t2\\ hyperintense\\ fusiform\\ tumor\\.\\ \\ on\\ t1\\ weighted\\ imaging\\,\\ the\\ mass\\ is\\ homogenous\\ and\\ isointense\\ to\\ muscle\\.\\ \\ the\\ tumor\\ strongly\\ enhances\\ follwing\\ gadolinium\\ administration\\.\\ \\ note\\ that\\ this\\ infiltrating\\ mass\\ is\\ contiguous\\ with\\ the\\ nerve\\.\ \(0\)\
\-\ neurofibroma\ \(78\)\
\-\ neurofibroma\\ vs\\ schwannoma\\ \\(neurilemmoma\\)\\.\\ \ \(0\)\
\-\ cat\\ scratch\\ disease\\ may\\ have\\ similar\\ plain\\ film\\ findings\\.\ \(0\)\
\-\ 52\\ year\\-old\\-male\\ presents\\ with\\ medial\\ elbow\\ pain\\.\ \(1\)\
\-\ while\\ neurofibromas\\ are\\ a\\ hallmark\\ of\\ nf\\ type\\ i\\,\\ only\\ 10\\%\\ of\\ patient\\'s\\ with\\ neurofibromas\\ actually\\ have\\ von\\ recklinghausen\\'s\\ disease\\.\\ \\ to\\ meet\\ diagnostic\\ criteria\\ for\\ nf\\ i\\,\\ a\\ patient\\ must\\ exhibit\\ two\\ of\\ the\\ following\\:\ \(0\)\
\-\ 6\\ or\\ more\\ caf\\?\\-au\\-lait\\ macules\\ \\(\\>5mm\\-prepuberty\\ or\\ \\>15mm\\-postpuberty\\)\\,\\ 2\\ or\\ more\\ neurofibromas\\ of\\ any\\ type\\ or\\ 1\\ plexiform\\ neurofibroma\\,\\ freckling\\ in\\ the\\ axillary\\ or\\ inguinal\\ regions\\,\\ optic\\ glioma\\,\\ 2\\ or\\ more\\ lisch\\ nodules\\,\\ distinctive\\ bony\\ lesion\\ \\(i\\.e\\.\\ sphenoid\\ dysplasia\\,\\ thinning\\ of\\ long\\ bone\\ cortex\\ with\\ or\\ without\\ pseudoarthrosis\\)\\,\\ a\\ first\\ degree\\ relative\\ diagnosed\\ with\\ nf1\\.\\ \ \(0\)\
\-\ while\\ malignant\\ transformation\\ is\\ rare\\,\\ this\\ would\\ present\\ with\\ indistinct\\ margins\\,\\ a\\ sudden\\ incrase\\ in\\ size\\ and\\ internal\\ areas\\ of\\ hemorrhage\\ and\\ necrosis\\.\ \(0\)\
\-\ lesions\\ usually\\ affect\\ young\\ adults\\ 20\\-30\\ years\\ without\\ sex\\ predilection\\.\ \(0\)\
\-\ unlike\\ schwannomas\\,\\ neurofibromas\\ are\\ intimately\\ intermixed\\ and\\ are\\ inseparable\\ from\\ the\\ normal\\ nerve\\ tissue\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ neurofibromas\\:\\ 0\\.3610825293786012\ \(0\)\
\-\ neurofibroma\\:\\ 0\\.21069992381485905\ \(0\)\
\-\ elbow\\:\\ 0\\.20112236580059908\ \(0\)\
\-\ nf\\:\\ 0\\.1769780852653538\ \(0\)\
\-\ or\\:\\ 0\\.1729429891885376\ \(0\)\
\-\ medial\\:\\ 0\\.1386833631648309\ \(0\)\
\-\ the\\:\\ 0\\.12753723677271506\ \(0\)\
\-\ more\\:\\ 0\\.11699058762602516\ \(0\)\
\-\ follwing\\:\\ 0\\.11357436289141727\ \(0\)\
\-\ incrase\\:\\ 0\\.11357436289141727\ \(0\)\
\-\ inseparable\\:\\ 0\\.11357436289141727\ \(0\)\
\-\ neurilemmoma\\:\\ 0\\.10852636703904085\ \(0\)\
\-\ mass\\:\\ 0\\.10850899089941386\ \(0\)\
\-\ freckling\\:\\ 0\\.10494475698308445\ \(0\)\
\-\ intimately\\:\\ 0\\.10494475698308445\ \(0\)\
\-\ scratch\\:\\ 0\\.10216664439338616\ \(0\)\
\-\ caf\\:\\ 0\\.10216664439338616\ \(0\)\
\-\ lisch\\:\\ 0\\.10216664439338616\ \(0\)\
\-\ intermixed\\:\\ 0\\.10216664439338616\ \(0\)\
\-\ nerve\\:\\ 0\\.10132874635613992\ \(0\)\
\-\ recklinghausen\\:\\ 0\\.09797760217757458\ \(0\)\
\-\ of\\:\\ 0\\.09728631738812155\ \(0\)\
\-\ cat\\:\\ 0\\.09631515107475165\ \(0\)\
\-\ type\\:\\ 0\\.09528412009736607\ \(0\)\
\-\ distinctive\\:\\ 0\\.0948487652783316\ \(0\)\
\-\ macules\\:\\ 0\\.09353703848505333\ \(0\)\
\-\ plexiform\\:\\ 0\\.09353703848505333\ \(0\)\
\-\ pseudoarthrosis\\:\\ 0\\.09353703848505333\ \(0\)\
\-\ hallmark\\:\\ 0\\.09235043726408432\ \(0\)\
\-\ while\\:\\ 0\\.09179594006535517\ \(0\)\
\-\ meet\\:\\ 0\\.09126715522237522\ \(0\)\
\-\ usually\\:\\ 0\\.0894178064858037\ \(0\)\
\-\ schwannomas\\:\\ 0\\.08693077531480532\ \(0\)\
\-\ nf1\\:\\ 0\\.08621915936999879\ \(0\)\
\-\ sex\\:\\ 0\\.08554602843156779\ \(0\)\
\-\ with\\:\\ 0\\.08343809651963906\ \(0\)\
\-\ exhibit\\:\\ 0\\.0821293199870222\ \(0\)\
\-\ predilection\\:\\ 0\\.0821293199870222\ \(0\)\
\-\ indistinct\\:\\ 0\\.08164102643631749\ \(0\)\
\-\ are\\:\\ 0\\.08084510076814097\ \(0\)\
\-\ unlike\\:\\ 0\\.079055939258086\ \(0\)\
\-\ von\\:\\ 0\\.07867283550337506\ \(0\)\
\-\ is\\:\\ 0\\.07779581451733789\ \(0\)\
\-\ actually\\:\\ 0\\.07758955346166597\ \(0\)\
\-\ fusiform\\:\\ 0\\.07659303058394105\ \(0\)\
\-\ homogenous\\:\\ 0\\.07537744241239475\ \(0\)\
\-\ thinning\\:\\ 0\\.07537744241239475\ \(0\)\
\-\ without\\:\\ 0\\.0749193888096127\ \(0\)\
\-\ tissue\\:\\ 0\\.07450961906876889\ \(0\)\
\-\ tumor\\:\\ 0\\.0742938016457616\ \(0\)\
\-\ affect\\:\\ 0\\.07349971407868938\ \(0\)\
\-\ contiguous\\:\\ 0\\.07325317355409608\ \(0\)\
\-\ transformation\\:\\ 0\\.07254155760928954\ \(0\)\
\-\ inguinal\\:\\ 0\\.07165190139329584\ \(0\)\
\-\ strongly\\:\\ 0\\.07143907758436417\ \(0\)\
\-\ sphenoid\\:\\ 0\\.07143907758436417\ \(0\)\
\-\ have\\:\\ 0\\.07095547275912306\ \(0\)\
\-\ in\\:\\ 0\\.07066859132636655\ \(0\)\
\-\ criteria\\:\\ 0\\.07042633334975319\ \(0\)\
\-\ findings\\:\\ 0\\.0701011545295732\ \(0\)\
\-\ axillary\\:\\ 0\\.06985600968130186\ \(0\)\
\-\ infiltrating\\:\\ 0\\.06967156349813969\ \(0\)\
\-\ adults\\:\\ 0\\.06632094132309412\ \(0\)\
\-\ 52\\:\\ 0\\.06577360528788563\ \(0\)\
\-\ rounded\\:\\ 0\\.06462356764576326\ \(0\)\
\-\ isointense\\:\\ 0\\.06426267601050138\ \(0\)\
\-\ relative\\:\\ 0\\.06291542882323181\ \(0\)\
\-\ enhances\\:\\ 0\\.06260022490767844\ \(0\)\
\-\ degree\\:\\ 0\\.06209199558065826\ \(0\)\
\-\ sudden\\:\\ 0\\.061413623686709426\ \(0\)\
\-\ optic\\:\\ 0\\.061133839111258415\ \(0\)\
\-\ regions\\:\\ 0\\.06095074919909804\ \(0\)\
\-\ schwannoma\\:\\ 0\\.06086020414800888\ \(0\)\
\-\ must\\:\\ 0\\.06086020414800888\ \(0\)\
\-\ margins\\:\\ 0\\.06059245426624391\ \(0\)\
\-\ glioma\\:\\ 0\\.060330341645000334\ \(0\)\
\-\ disease\\:\\ 0\\.05962225500949496\ \(0\)\
\-\ gadolinium\\:\\ 0\\.05917521930211349\ \(0\)\
\-\ and\\:\\ 0\\.058700579905743844\ \(0\)\
\-\ young\\:\\ 0\\.05856028494881117\ \(0\)\
\-\ cortex\\:\\ 0\\.05783201363075304\ \(0\)\
\-\ administration\\:\\ 0\\.0565557061775771\ \(0\)\
\-\ hyperintense\\:\\ 0\\.056492023738733424\ \(0\)\
\-\ nodules\\:\\ 0\\.056428665384950456\ \(0\)\
\-\ excision\\:\\ 0\\.05599396173743044\ \(0\)\
\-\ bony\\:\\ 0\\.05471890622147199\ \(0\)\
\-\ dysplasia\\:\\ 0\\.05439268957663021\ \(0\)\
\-\ necrosis\\:\\ 0\\.05428582291489899\ \(0\)\
\-\ vs\\:\\ 0\\.05417986576769853\ \(0\)\
\-\ similar\\:\\ 0\\.054127223449737055\ \(0\)\
\-\ diagnostic\\:\\ 0\\.054127223449737055\ \(0\)\
\-\ rare\\:\\ 0\\.053612691976468\ \(0\)\
\-\ note\\:\\ 0\\.053462389672325444\ \(0\)\
\-\ film\\:\\ 0\\.053070234743352686\ \(0\)\
\-\ weighted\\:\\ 0\\.052974096121620726\ \(0\)\
\-\ radiographic\\:\\ 0\\.052690055901059456\ \(0\)\
\-\ diagnosed\\:\\ 0\\.05144402788635699\ \(0\)\
\-\ malignant\\:\\ 0\\.05062466057773493\ \(0\)\
\-\ muscle\\:\\ 0\\.05042797576596288\ \(0\)\
\-\ would\\:\\ 0\\.050272834946623025\ \(0\)\
\-\ palpable\\:\\ 0\\.04989323573511574\ \(0\)\
\-\ this\\:\\ 0\\.048806608857311834\ \(0\)\
\-\ areas\\:\\ 0\\.048216772374596685\ \(0\)\
\-\ size\\:\\ 0\\.04808674623554485\ \(0\)\
\-\ first\\:\\ 0\\.04792610026924429\ \(0\)\
\-\ internal\\:\\ 0\\.04786241783040061\ \(0\)\
\-\ hemorrhage\\:\\ 0\\.047548802012259805\ \(0\)\
\-\ long\\:\\ 0\\.0470927110967929\ \(0\)\
\-\ plain\\:\\ 0\\.04685612650207743\ \(0\)\
\-\ patient\\:\\ 0\\.04619763609657637\ \(0\)\
\-\ any\\:\\ 0\\.045897970032677586\ \(0\)\
\-\ aspect\\:\\ 0\\.04581686297286673\ \(0\)\
\-\ examination\\:\\ 0\\.04544519687596417\ \(0\)\
\-\ only\\:\\ 0\\.04436845535956903\ \(0\)\
\-\ t1\\:\\ 0\\.04424908829321294\ \(0\)\
\-\ years\\:\\ 0\\.04353351308946104\ \(0\)\
\-\ following\\:\\ 0\\.04260446945361833\ \(0\)\
\-\ include\\:\\ 0\\.04225548019942436\ \(0\)\
\-\ two\\:\\ 0\\.04217476750409979\ \(0\)\
\-\ 10\\:\\ 0\\.041528129084600234\ \(0\)\
\-\ t2\\:\\ 0\\.04085901877906348\ \(0\)\
\-\ lesions\\:\\ 0\\.04078684530361264\ \(0\)\
\-\ bone\\:\\ 0\\.03875001649490192\ \(0\)\
\-\ soft\\:\\ 0\\.037808844870767765\ \(0\)\
\-\ imaging\\:\\ 0\\.037322730541081865\ \(0\)\
\-\ mri\\:\\ 0\\.03645469933236948\ \(0\)\
\-\ present\\:\\ 0\\.036442001840551075\ \(0\)\
\-\ may\\:\\ 0\\.03573884945123621\ \(0\)\
\-\ demonstrates\\:\\ 0\\.03567902286014402\ \(0\)\
\-\ to\\:\\ 0\\.035509071238276256\ \(0\)\
\-\ surgical\\:\\ 0\\.034517405066999754\ \(0\)\
\-\ presents\\:\\ 0\\.03416366077207975\ \(0\)\
\-\ lesion\\:\\ 0\\.03404794486837611\ \(0\)\
\-\ treatment\\:\\ 0\\.03382997541372176\ \(0\)\
\-\ that\\:\\ 0\\.030819452698602708\ \(0\)\
\-\ normal\\:\\ 0\\.028996459208086495\ \(0\)\
\-\ from\\:\\ 0\\.02820561695243156\ \(0\)\
\-\ pain\\:\\ 0\\.025413104614938325\ \(0\)\
\-\ for\\:\\ 0\\.021525223071172127\ \(0\)\
\-\ on\\:\\ 0\\.021448866562898745\ \(0\)\
